Valanciene Egle, Malys Naglis
Bioprocess Research Centre, Faculty of Chemical Technology, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania.
Department of Organic Chemistry, Faculty of Chemical Technology, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania.
Antioxidants (Basel). 2022 Dec 9;11(12):2427. doi: 10.3390/antiox11122427.
Hydroxycinnamoyl-quinic acids (HCQAs) are polyphenol esters formed of hydroxycinnamic acids and (-)-quinic acid. They are naturally synthesized by plants and some micro-organisms. The ester of caffeic acid and quinic acid, the chlorogenic acid, is an intermediate of lignin biosynthesis. HCQAs are biologically active dietary compounds exhibiting several important therapeutic properties, including antioxidant, antimicrobial, anti-inflammatory, neuroprotective, and other activities. They can also be used in the synthesis of nanoparticles or drugs. However, extraction of these compounds from biomass is a complex process and their synthesis requires costly precursors, limiting the industrial production and availability of a wider variety of HCQAs. The recently emerged production through the bioconversion is still in an early stage of development. In this paper, we discuss existing and potential future strategies for production of HCQAs.
羟基肉桂酰奎宁酸(HCQAs)是由羟基肉桂酸和(-)-奎宁酸形成的多酚酯。它们由植物和一些微生物天然合成。咖啡酸和奎宁酸的酯,即绿原酸,是木质素生物合成的中间体。HCQAs是具有生物活性的膳食化合物,具有多种重要的治疗特性,包括抗氧化、抗菌、抗炎、神经保护等活性。它们还可用于纳米颗粒或药物的合成。然而,从生物质中提取这些化合物是一个复杂的过程,并且它们的合成需要昂贵的前体,这限制了多种HCQAs的工业化生产和可得性。最近出现的通过生物转化进行生产仍处于早期发展阶段。在本文中,我们讨论了生产HCQAs的现有策略和潜在的未来策略。